Literature DB >> 26217080

MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity.

Michael Hollis1, Kavitha Nair1, Arpita Vyas1, Lakshmi Shankar Chaturvedi1, Sahil Gambhir1, Dinesh Vyas1.   

Abstract

Over the past decade, research has shown that aberrant expression of microRNA (miRNA) is involved in colorectal cancer development and progression. MicroRNAs are small sequences of non-coding RNA that regulate expression of genes involved in important cellular functions, such as cell differentiation, multiplication, and apoptosis. A specific miRNA may display the effects of a tumor suppressor or oncogene. Altered miRNA expression is found in colorectal cancer (CRC) and patterns of miRNA expression correlate with CRC detection and outcome. Studies also have examined the use of circulating serum miRNA and fecal miRNA expression as non-invasive markers for early detection. Here, we review recent evidence demonstrating the potential role of miRNA in CRC and the implications of its use in the diagnosis, prognosis, and management of CRC.

Entities:  

Keywords:  Colorectal cancer; Diagnostic; Expression; Fecal microRNA; MicroRNA; Prognostic; Serum microRNA; Therapeutic

Mesh:

Substances:

Year:  2015        PMID: 26217080      PMCID: PMC4507098          DOI: 10.3748/wjg.v21.i27.8284

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  71 in total

1.  A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.

Authors:  Ziad Kanaan; Henry Roberts; M Robert Eichenberger; Adrian Billeter; Gairy Ocheretner; Jianmin Pan; Shesh N Rai; Jeffery Jorden; Anna Williford; Susan Galandiuk
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

2.  Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.

Authors:  J B Kjersem; T Ikdahl; O C Lingjaerde; T Guren; K M Tveit; E H Kure
Journal:  Mol Oncol       Date:  2013-09-21       Impact factor: 6.603

3.  Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

Authors:  Vinod Gopalan; Suja Pillai; Faeza Ebrahimi; Ali Salajegheh; Tommy C Lam; Tran K Le; Nicole Langsford; Yik-Hong Ho; Robert A Smith; Alfred K-Y Lam
Journal:  Mol Carcinog       Date:  2013-09-05       Impact factor: 4.784

4.  Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.

Authors:  Yingjie Yu; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

5.  Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Chyke A Doubeni; Adeyinka O Laiyemo; Jacqueline M Major; Mario Schootman; Min Lian; Yikyung Park; Barry I Graubard; Albert R Hollenbeck; Rashmi Sinha
Journal:  Cancer       Date:  2012-01-03       Impact factor: 6.860

Review 6.  Alterations of microRNAs contribute to colon carcinogenesis.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

7.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

8.  Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.

Authors:  Jennifer L Spratlin; David Hui; John Hanson; Charles Butts; Heather-Jane Au
Journal:  Clin Colorectal Cancer       Date:  2008-03       Impact factor: 4.481

9.  MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.

Authors:  Juan Li; Lutao Du; Yongmei Yang; Chuanxin Wang; Hui Liu; Lili Wang; Xin Zhang; Wei Li; Guixi Zheng; Zhaogang Dong
Journal:  Cancer Lett       Date:  2012-10-27       Impact factor: 8.679

10.  Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.

Authors:  Chung Wah Wu; Siew Chien Ng; Yujuan Dong; Linwei Tian; Simon Siu Man Ng; Wing Wa Leung; Wai Tak Law; Tung On Yau; Francis Ka Leung Chan; Joseph Jao Yiu Sung; Jun Yu
Journal:  Clin Cancer Res       Date:  2014-04-01       Impact factor: 12.531

View more
  53 in total

1.  Circulating miRNAs and their target genes associated with arsenism caused by coal-burning.

Authors:  Baofei Sun; Junchao Xue; Jun Li; Fei Luo; Xiong Chen; Yonglian Liu; Qingling Wang; Caihua Qi; Zhonglan Zou; Aihua Zhang; Qizhan Liu
Journal:  Toxicol Res (Camb)       Date:  2017-01-23       Impact factor: 3.524

Review 2.  Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Shanthi Sabarimurugan; Madurantakam Royam Madhav; Chellan Kumarasamy; Ajay Gupta; Siddharta Baxi; Sunil Krishnan; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

3.  SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.

Authors:  Jian Zhao; Jian Xu; Rui Zhang
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

4.  Berberine regulates the microRNA-21-ITGΒ4-PDCD4 axis and inhibits colon cancer viability.

Authors:  Yanfeng Lü; Bingbing Han; Hualong Yu; Zhenghua Cui; Zhiwen Li; Jianxin Wang
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

5.  Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.

Authors:  Madhav Madurantakam Royam; Chellan Kumarasamy; Siddhartha Baxi; Ajay Gupta; Nachimuthu Ramesh; Gothandam Kodiveri Muthukaliannan; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

6.  Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Genetic Engineering: Robotic Genetic Surgery.

Authors:  Kaivalya Deshpande; Arpita Vyas; Archana Balakrishnan; Dinesh Vyas
Journal:  Am J Robot Surg       Date:  2015-12

7.  Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.

Authors:  Jian Li; Yuxiang Chen; Xiong Guo; Ling Zhou; Zeming Jia; Yaping Tang; Ling Lin; Weidong Liu; Caiping Ren
Journal:  Tumour Biol       Date:  2016-01-07

8.  Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas.

Authors:  Likun Hou; Jian Chen; Yuhui Zheng; Chunyan Wu
Journal:  Tumour Biol       Date:  2015-11-09

Review 9.  Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.

Authors:  Chandra Kishore; Devarajan Karunagaran
Journal:  Mol Cell Biochem       Date:  2022-03-24       Impact factor: 3.396

10.  Prediction of miRNA-Disease Association Using Deep Collaborative Filtering.

Authors:  Li Wang; Cheng Zhong
Journal:  Biomed Res Int       Date:  2021-02-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.